Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methyl-ethyl)amino]sulfonyl]benzamide

US8362026B2 · kind B2 · utility

Assignee

• BASF SE

Inventors

• Thomas Schmidt · Neustadt, DE
• Joachim Gebhardt · Monsheim, DE
• Sandra Löhr · Ludwigshafen, DE
• Michael Keil · Freinsheim, DE
• Jan Hendrik Wevers · Zörbig, DE
• Peter Erk · Bischofswerda, DE
• Heidi Emilia Saxell · Hallenberg, DE
• Gerhard Hamprecht · Weinheim, DE
• Werner Seitz · Plankstadt, DE
• Guido Mayer · Neheim, DE
• Bernd Wolf · Niederkirchen, DE
• Gerhard Cox · Bad Dürkheim, DE
• Alfred Michel · Winnweiler, DE
• Cyrill Zagar · Ludwigshafen, DE
• Robert Reinhard · Schifferstadt, DE
• Bernd Sievernich · Böhl-Iggelheim, DE

Key dates

• Filing date: Oct 12, 2007
• Grant date: Jan 29, 2013
• Expiry date: Nov 26, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D239/54
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to a crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)-amino]sulfonyl]benzamide. The invention also relates to a process for the preparation of this crystalline form and to plant protection formulations which comprise this crystalline form of the phenyluracil.